Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection

The authors validated a dried blood spot assay for benznidazole that showed strong agreement with plasma concentrations (r²=0.8295) and proved stable at room temperature for more than one year. This microsampling approach enables therapeutic drug monitoring for Chagas disease in decentralised trials and remote settings, including paediatric populations.

Dried Blood Spot Technique-Based Liquid Chromatography-Tandem Mass Spectrometry Method as a Simple Alternative for Benznidazole Pharmacokinetic Assessment — Galindo Bedor et al., Antimicrobial agents and chemotherapy · source ↗

• venous-agreement
• blood
• dbs
• tdm
• haematocrit
• dried
• antimicrobials
• pediatric
• validation

The validation of a dried blood spot assay for ceftriaxone achieved a limit of quantification of 0.14 mg/L with strong correlation between DBS-predicted and measured plasma concentrations (r=0.95). The method showed acceptable thermal stability, retaining over 95% of initial concentrations for periods ranging from 14 hours to 11 months. This supports the use of self-collected DBS samples for therapeutic drug monitoring of antimicrobials in remote and resource-poor settings.

Validation and Application of a Dried Blood Spot Ceftriaxone Assay — Page-Sharp et al., Antimicrobial agents and chemotherapy (paywalled) · source ↗

• blood
• dried
• dbs
• validation
• venous-agreement
• tdm
• antimicrobials
• haematocrit

Parsons et al. validated a quantitative dried blood spot assay for rifapentine that remained stable for 11 weeks at ambient temperature and showed good agreement with plasma concentrations after haematocrit correction, offering a low-volume sampling approach suitable for therapeutic drug monitoring in international and paediatric tuberculosis trials.

Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis — Parsons et al., Antimicrobial agents and chemotherapy (paywalled) · source ↗

• blood
• dried
• dbs
• validation
• venous-agreement
• tdm
• antimicrobials
• haematocrit

In AML and CLL, 91% of VAMS venetoclax results fell within 20% of plasma after individualised haematocrit correction; in home sampling, 18 of 21 patients self-sampled independently and 76% of returned samples were analysable, which shows home microsampling is workable, though the authors ask for multicentre validation.

Clinical Validation of Venetoclax Volumetric Microsampling in Leukemia, with Whole-Blood-to-Plasma Conversion and Self-Microsampling Feasibility — Levens et al., Clinical Pharmacokinetics (paywalled) · source ↗

• vams
• venous-agreement
• blood
• dbs
• tdm
• self-collection
• haematocrit
• dried
• oncology
• capillary
• validation

The study validated an LC-MS/MS method for eight antiepileptic drugs and two metabolites in dried blood spot and VAMS formats, with satisfactory analytical performance and stability, and was the first to include the oxcarbazepine metabolite DHCB. In 80 paired patient samples, microsampling concentrations showed promising correlation with plasma, supporting decentralised therapeutic drug monitoring of antiepileptic treatment.

Development and application of an LC-MS/MS method for 8 antiepileptic drugs and 2 metabolites using microsampling techniques (DBS and VAMS) — Cobo-Golpe et al., Journal of analytical toxicology · source ↗

• blood
• dried
• vams
• dbs
• neoteryx-mitra
• validation
• venous-agreement
• tdm
• haematocrit